Product Information
PIOGLITAZONE-METFORMIN 15-850 is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2750 per EA under NDC 57237021860. Its NADAC has been published 514 times since Oct 19, 2016.
FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850; 15 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237021860
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200823FDA Approved
2/13/2013
TE Code
AB
On Market Since
2/13/2013
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE-METFORMIN 15-850 has been published 514 times since Oct 19, 2016, and over the history we have for it it has declined 84.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2750 per EA |
|---|---|
| All-time high | $1.7583 (Nov 16, 2016) |
| All-time low | $0.2180 (May 22, 2024) |
| 52-week high | $0.3035 |
| 52-week low | $0.2750 |
| Median price | $0.5714 |
| Average price | $0.6076 |
| Largest weekly change | -54.8% (Sep 20, 2023) |
| Weeks tracked | 514 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIOGLITAZONE-METFORMIN 15-850?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-850, manufactured by Rising Pharma Holdings Inc., is $0.2750 per EA (NDC 57237021860), effective Aug 19, 2026.
How has the price of PIOGLITAZONE-METFORMIN 15-850 changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has declined 84.4%. It has been tracked across 514 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-850?
Since Oct 19, 2016, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has ranged from a low of $0.2180 (May 22, 2024) to a high of $1.7583 (Nov 16, 2016), with a median of $0.5714 per EA.
Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-850?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE-METFORMIN 15-850 in a comparable dosage form, but none are currently priced below it.
Who manufactures PIOGLITAZONE-METFORMIN 15-850?
PIOGLITAZONE-METFORMIN 15-850 (NDC 57237021860) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.